Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 21; no. 8; pp. 1141 - 1142
Main Authors Mercader, P, Rodenas, JM, Peña, A, Mascaro Jr, JM
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.09.2007
Subjects
Aged
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents - adverse effects
Epidermolysis Bullosa Acquisita - drug therapy
Fatal Outcome
Humans
Male
Pneumonia, Bacterial - chemically induced
Pseudomonas Infections - chemically induced
Rituximab
Online AccessGet full text
ISSN0926-9959
1468-3083
DOI10.1111/j.1468-3083.2006.02127.x

Cover

More Information
Bibliography:ArticleID:JDV2127
istex:4DD8919282524C33DB3FB4F6384336D12E45BF3B
ark:/67375/WNG-Q8P12X1K-D
Conflict of interest to disclose: Nil. Financial disclosures: Nil. Specific contributions: P. Mercader, A. Peña and JM Rodenas visited the patient in Murcia; JM Mascaro Jr made the IFI.
DOI: 10.1111/j.1468‐3083.2006.02127.x
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0926-9959
1468-3083
DOI:10.1111/j.1468-3083.2006.02127.x